Valneva announces the launch of a private placement of ordinary shares for approximately 60 million euros

Saint-herblain (france), september 12, 2024 – valneva se (nasdaq: valn; euronext paris: vla) (“valneva” or the “company”), a specialty vaccine company, today announces its intention to issue, subject to market conditions, approximately 22.6 million new ordinary shares (the “offer shares”) at a price of €2.66 per offer share to certain categories of investors via a private placement through an accelerated bookbuilding process starting immediately.
VALN Ratings Summary
VALN Quant Ranking